Building quality into HTA/coverage decision-making processes: What are the features of good practice in HTA?
2-3 December 2013, Heathrow, UK
This workshop continued the work of the CIRS September 2011 workshop, Understanding HTA and Coverage decision-marking processes, which focused on the question: what is the key to facilitating transparent access to medicine? It especially dealt with how to build process consistency and quality into both HTA and coverage decision making, as well as on the quality of the submission so as to improve the process of bringing a new medicine to market.
Workshop objectives
- Ascertain companies’ and agencies’ current perspectives with regard to the quality of HTA/coverage decision-making processes
- Identify and discuss the key aspect of a good-practice process of HTA and coverage decision making
- Identify the key factors that enable companies to prepare a quality submission in an evolving HTA environment
- Recommend which key features should be considered or adopted for best practice in HTA processes and decision making